These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 22124950)

  • 1. Bioguided isolation of (9Z)-octadec-9-enoic acid from Phellodendron amurense Rupr. and identification of fatty acids as PTP1B inhibitors.
    Steinmann D; Baumgartner RR; Heiss EH; Bartenstein S; Atanasov AG; Dirsch VM; Ganzera M; Stuppner H
    Planta Med; 2012 Feb; 78(3):219-24. PubMed ID: 22124950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of a novel proteoglycan PTP1B inhibitor from Ganoderma lucidum on the amelioration of hyperglycaemia and dyslipidaemia in db/db mice.
    Wang CD; Teng BS; He YM; Wu JS; Pan D; Pan LF; Zhang D; Fan ZH; Yang HJ; Zhou P
    Br J Nutr; 2012 Dec; 108(11):2014-25. PubMed ID: 22453054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological profiles of a novel protein tyrosine phosphatase 1B inhibitor, JTT-551.
    Fukuda S; Ohta T; Sakata S; Morinaga H; Ito M; Nakagawa Y; Tanaka M; Matsushita M
    Diabetes Obes Metab; 2010 Apr; 12(4):299-306. PubMed ID: 20380650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of the protein tyrosine phosphatase PTP1B: potential therapy for obesity, insulin resistance and type-2 diabetes mellitus.
    Koren S; Fantus IG
    Best Pract Res Clin Endocrinol Metab; 2007 Dec; 21(4):621-40. PubMed ID: 18054739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and biological evaluation of 2,4,6-trihydroxychalcone derivatives as novel protein tyrosine phosphatase 1B inhibitors.
    Sun LP; Gao LX; Ma WP; Nan FJ; Li J; Piao HR
    Chem Biol Drug Des; 2012 Oct; 80(4):584-90. PubMed ID: 22805439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of protein tyrosine phosphatase 1B by ursane-type triterpenes isolated from Symplocos paniculata.
    Na M; Yang S; He L; Oh H; Kim BS; Oh WK; Kim BY; Ahn JS
    Planta Med; 2006 Feb; 72(3):261-3. PubMed ID: 16534732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prodrug delivery of novel PTP1B inhibitors to enhance insulin signalling.
    Erbe DV; Klaman LD; Wilson DP; Wan ZK; Kirincich SJ; Will S; Xu X; Kung L; Wang S; Tam S; Lee J; Tobin JF
    Diabetes Obes Metab; 2009 Jun; 11(6):579-88. PubMed ID: 19383031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein tyrosine phosphatase 1B inhibitory by dammaranes from Vietnamese Giao-Co-Lam tea.
    Hung TM; Hoang DM; Kim JC; Jang HS; Ahn JS; Min BS
    J Ethnopharmacol; 2009 Jul; 124(2):240-5. PubMed ID: 19397985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fumosorinone, a novel PTP1B inhibitor, activates insulin signaling in insulin-resistance HepG2 cells and shows anti-diabetic effect in diabetic KKAy mice.
    Liu ZQ; Liu T; Chen C; Li MY; Wang ZY; Chen RS; Wei GX; Wang XY; Luo DQ
    Toxicol Appl Pharmacol; 2015 May; 285(1):61-70. PubMed ID: 25796170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and biological evaluation of 4,4-dimethyl lithocholic acid derivatives as novel inhibitors of protein tyrosine phosphatase 1B.
    He HB; Gao LX; Deng QF; Ma WP; Tang CL; Qiu WW; Tang J; Li JY; Li J; Yang F
    Bioorg Med Chem Lett; 2012 Dec; 22(23):7237-42. PubMed ID: 23067554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. α-Methyl artoflavanocoumarin from Juniperus chinensis exerts anti-diabetic effects by inhibiting PTP1B and activating the PI3K/Akt signaling pathway in insulin-resistant HepG2 cells.
    Jung HJ; Seong SH; Ali MY; Min BS; Jung HA; Choi JS
    Arch Pharm Res; 2017 Dec; 40(12):1403-1413. PubMed ID: 29177868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Role of protein tyrosine phosphatase 1B in the type 2 diabetes and obesity].
    Wang C; Wang L; Yang Z
    Yi Chuan; 2004 Nov; 26(6):941-6. PubMed ID: 15640130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting protein tyrosine phosphatase to enhance insulin action for the potential treatment of diabetes.
    Kasibhatla B; Wos J; Peters KG
    Curr Opin Investig Drugs; 2007 Oct; 8(10):805-13. PubMed ID: 17907056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Docking Assisted Prediction and Biological Evaluation of Sideritis L. Components with PTP1b Inhibitory Action and Probable Anti-Diabetic Properties.
    Eleftheriou P; Therianou E; Lazari D; Dirnali S; Micha A
    Curr Top Med Chem; 2019; 19(5):383-392. PubMed ID: 30806317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein tyrosine phosphatase 1B as a target for the treatment of impaired glucose tolerance and type II diabetes.
    Liu G; Trevillyan JM
    Curr Opin Investig Drugs; 2002 Nov; 3(11):1608-16. PubMed ID: 12476961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dammaranes from Gynostemma pentaphyllum and synthesis of their derivatives as inhibitors of protein tyrosine phosphatase 1B.
    Xu JQ; Shen Q; Li J; Hu LH
    Bioorg Med Chem; 2010 Jun; 18(11):3934-9. PubMed ID: 20472439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PTP1B as a drug target: recent developments in PTP1B inhibitor discovery.
    Zhang S; Zhang ZY
    Drug Discov Today; 2007 May; 12(9-10):373-81. PubMed ID: 17467573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pyrroloquinoline quinone, a novel protein tyrosine phosphatase 1B inhibitor, activates insulin signaling in C2C12 myotubes and improves impaired glucose tolerance in diabetic KK-A(y) mice.
    Takada M; Sumi M; Maeda A; Watanabe F; Kamiya T; Ishii T; Nakano M; Akagawa M
    Biochem Biophys Res Commun; 2012 Nov; 428(2):315-20. PubMed ID: 23085227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular dynamics approach to probe the allosteric inhibition of PTP1B by chlorogenic and cichoric acid.
    Baskaran SK; Goswami N; Selvaraj S; Muthusamy VS; Lakshmi BS
    J Chem Inf Model; 2012 Aug; 52(8):2004-12. PubMed ID: 22747429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel protein tyrosine phosphatase 1B inhibitors: interaction requirements for improved intracellular efficacy in type 2 diabetes mellitus and obesity control.
    Popov D
    Biochem Biophys Res Commun; 2011 Jul; 410(3):377-81. PubMed ID: 21683066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.